ArcherDX Company Profile: Funding, Investors & Partnerships

ArcherDX

ArcherDX creates catalog and custom next-generation sequencing (NGS) assays that are purpose-built to identify mutations and gene fusions from clinical sample types. By combining novel enrichment chemistry, automated informatics and a user-friendly workflow, Archer® products remove the bottlenecks associated with using next-gen sequencing in a translational setting.ArcherDX creates catalog and custom next-generation sequencing (NGS) assays that are purpose-built t Show More

Alpha Score

57.9

Total Funding$ 1.55 B